HCPCS J Codes | Complete List (Updated 2024)

Welcome to our in-depth guide on HCPCS J Codes, a vital aspect of medical billing and coding. These codes play a pivotal role in accurately documenting and reimbursing for drugs administered through methods other than oral ingestion, with a particular focus on chemotherapy drugs. This comprehensive guide aims to provide a detailed understanding of HCPCS J-Codes, their significance, and how they are utilized in the healthcare industry. Additionally we discover where these codes applied and list of HCPCS J Codes with detailed descriptions.

HCPCS J Codes

HCPCS J Codes

Drugs administered other than oral method, chemotherapy drugs

HCPCS J CodesHCPCS J-Codes
J0120 Injection, tetracycline, up to 250 mg
J0121 Injection, omadacycline, 1 mg
J0122 Injection, eravacycline, 1 mg
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0130 Injection abciximab, 10 mg
J0131 Injection, acetaminophen, not otherwise specified,10 mg
J0132 Injection, acetylcysteine, 100 mg
J0133 Injection, acyclovir, 5 mg
J0134 Injection, acetaminophen (fresenius kabi) not therapeutically equivalent to j0131, 10 mg
J0135 Injection, adalimumab, 20 mg
J0136 Injection, acetaminophen (b braun) not therapeutically equivalent to j0131, 10 mg
J0137 Injection, acetaminophen (hikma) not therapeutically equivalent to j0131, 10 mg
J0150 Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
J0151 Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
J0171 Injection, adrenalin, epinephrine, 0.1 mg
J0172 Injection, aducanumab-avwa, 2 mg
J0173 Injection, epinephrine (belcher) not therapeutically equivalent to j0171, 0.1 mg
J0174 Injection, lecanemab-irmb, 1 mg
J0178 Injection, aflibercept, 1 mg
J0179 Injection, brolucizumab-dbll, 1 mg
J0180 Injection, agalsidase beta, 1 mg
J0184 Injection, amisulpride, 1 mg   New
J0185 Injection, aprepitant, 1 mg
J0190 Injection, biperiden lactate, per 5 mg
J0200 Injection, alatrofloxacin mesylate, 100 mg
J0202 Injection, alemtuzumab, 1 mg
J0205 Injection, alglucerase, per 10 units
J0206 Injection, allopurinol sodium, 1 mg
J0207 Injection, amifostine, 500 mg
J0208 Injection, sodium thiosulfate, 100 mg
J0210 Injection, methyldopate hcl, up to 250 mg
J0215 Injection, alefacept, 0.5 mg
J0216 Injection, alfentanil hydrochloride, 500 micrograms
J0217 Injection, velmanase alfa-tycv, 1 mg   New
J0218 Injection, olipudase alfa-rpcp, 1 mg
J0219 Injection, avalglucosidase alfa-ngpt, 4 mg
J0220 Injection, alglucosidase alfa, 10 mg, not otherwise specified
J0221 Injection, alglucosidase alfa, (lumizyme), 10 mg
J0222 Injection, patisiran, 0.1 mg
J0223 Injection, givosiran, 0.5 mg
J0224 Injection, lumasiran, 0.5 mg
J0225 Injection, vutrisiran, 1 mg
J0248 Injection, remdesivir, 1 mg
J0256 Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg
J0257 Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg
J0270 Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0275 Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0278 Injection, amikacin sulfate, 100 mg
J0280 Injection, aminophyllin, up to 250 mg
J0282 Injection, amiodarone hydrochloride, 30 mg
J0283 Injection, amiodarone hydrochloride (nexterone), 30 mg
J0285 Injection, amphotericin b, 50 mg
J0287 Injection, amphotericin b lipid complex, 10 mg
J0288 Injection, amphotericin b cholesteryl sulfate complex, 10 mg
J0289 Injection, amphotericin b liposome, 10 mg
J0290 Injection, ampicillin sodium, 500 mg
J0291 Injection, plazomicin, 5 mg
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm
J0300 Injection, amobarbital, up to 125 mg
J0330 Injection, succinylcholine chloride, up to 20 mg
J0348 Injection, anidulafungin, 1 mg
J0349 Injection, rezafungin, 1 mg
J0350 Injection, anistreplase, per 30 units
J0360 Injection, hydralazine hcl, up to 20 mg
J0364 Injection, apomorphine hydrochloride, 1 mg
J0365 Injection, aprotonin, 10,000 kiu
J0380 Injection, metaraminol bitartrate, per 10 mg
J0390 Injection, chloroquine hydrochloride, up to 250 mg
J0391 Injection, artesunate, 1 mg   New
J0395 Injection, arbutamine hcl, 1 mg
J0400 Injection, aripiprazole, intramuscular, 0.25 mg
J0401 Injection, aripiprazole, extended release, 1 mg
J0402 Injection, aripiprazole (abilify asimtufii), 1 mg   New
J0456 Injection, azithromycin, 500 mg
J0457 Injection, aztreonam, 100 mg
J0461 Injection, atropine sulfate, 0.01 mg
J0470 Injection, dimercaprol, per 100 mg
J0475 Injection, baclofen, 10 mg
J0476 Injection, baclofen, 50 mcg for intrathecal trial
J0480 Injection, basiliximab, 20 mg
J0485 Injection, belatacept, 1 mg
J0490 Injection, belimumab, 10 mg
J0491 Injection, anifrolumab-fnia, 1 mg
J0500 Injection, dicyclomine hcl, up to 20 mg
J0515 Injection, benztropine mesylate, per 1 mg
J0517 Injection, benralizumab, 1 mg
J0520 Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
J0558 Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
J0561 Injection, penicillin g benzathine, 100,000 units
J0565 Injection, bezlotoxumab, 10 mg
J0567 Injection, cerliponase alfa, 1 mg
J0570 Buprenorphine implant, 74.2 mg
J0571 Buprenorphine, oral, 1 mg
J0572 Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
J0573 Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
J0574 Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
J0575 Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
J0576 Injection, buprenorphine extended-release (brixadi), 1 mg   New
J0583 Injection, bivalirudin, 1 mg
J0584 Injection, burosumab-twza 1 mg
J0585 Injection, onabotulinumtoxina, 1 unit
J0586 Injection, abobotulinumtoxina, 5 units
J0587 Injection, rimabotulinumtoxinb, 100 units
J0588 Injection, incobotulinumtoxin a, 1 unit
J0591 Injection, deoxycholic acid, 1 mg
J0592 Injection, buprenorphine hydrochloride, 0.1 mg
J0593 Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
J0594 Injection, busulfan, 1 mg
J0595 Injection, butorphanol tartrate, 1 mg
J0596 Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
J0597 Injection, c-1 esterase inhibitor (human), berinert, 10 units
J0598 Injection, c-1 esterase inhibitor (human), cinryze, 10 units
J0599 Injection, c-1 esterase inhibitor (human), (haegarda), 10 units
J0600 Injection, edetate calcium disodium, up to 1000 mg
J0604 Cinacalcet, oral, 1 mg, (for esrd on dialysis)
J0606 Injection, etelcalcetide, 0.1 mg
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml
J0611 Injection, calcium gluconate (wg critical care), per 10 ml
J0612 Injection, calcium gluconate (fresenius kabi), per 10 mg
J0613 Injection, calcium gluconate (wg critical care), per 10 mg
J0620 Injection, calcium glycerophosphate and calcium lactate, per 10 ml
J0630 Injection, calcitonin salmon, up to 400 units
J0636 Injection, calcitriol, 0.1 mcg
J0637 Injection, caspofungin acetate, 5 mg
J0638 Injection, canakinumab, 1 mg
J0640 Injection, leucovorin calcium, per 50 mg
J0641 Injection, levoleucovorin, not otherwise specified, 0.5 mg
J0642 Injection, levoleucovorin (khapzory), 0.5 mg
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg
J0670 Injection, mepivacaine hydrochloride, per 10 ml
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg   New
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
J0690 Injection, cefazolin sodium, 500 mg
J0691 Injection, lefamulin, 1 mg
J0692 Injection, cefepime hydrochloride, 500 mg
J0693 Injection, cefiderocol, 5 mg
J0694 Injection, cefoxitin sodium, 1 gm
J0695 Injection, ceftolozane 50 mg and tazobactam 25 mg
J0696 Injection, ceftriaxone sodium, per 250 mg
J0697 Injection, sterile cefuroxime sodium, per 750 mg
J0698 Injection, cefotaxime sodium, per gm
J0699 Injection, cefiderocol, 10 mg
J0701 Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
J0703 Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
J0706 Injection, caffeine citrate, 5 mg
J0710 Injection, cephapirin sodium, up to 1 gm
J0712 Injection, ceftaroline fosamil, 10 mg
J0713 Injection, ceftazidime, per 500 mg
J0714 Injection, ceftazidime and avibactam, 0.5 g/0.125 g
J0715 Injection, ceftizoxime sodium, per 500 mg
J0716 Injection, centruroides immune f(ab)2, up to 120 milligrams
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0720 Injection, chloramphenicol sodium succinate, up to 1 gm
J0725 Injection, chorionic gonadotropin, per 1,000 usp units
J0735 Injection, clonidine hydrochloride, 1 mg
J0736 Injection, clindamycin phosphate, 300 mg
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
J0739 Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
J0740 Injection, cidofovir, 375 mg
J0741 Injection, cabotegravir and rilpivirine, 2mg/3mg
J0742 Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
J0743 Injection, cilastatin sodium; imipenem, per 250 mg
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg
J0745 Injection, codeine phosphate, per 30 mg
J0750 Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)   New
J0751 Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)   New
J0760 Injection, colchicine, per 1 mg
J0770 Injection, colistimethate sodium, up to 150 mg
J0775 Injection, collagenase, clostridium histolyticum, 0.01 mg
J0780 Injection, prochlorperazine, up to 10 mg
J0791 Injection, crizanlizumab-tmca, 5 mg
J0795 Injection, corticorelin ovine triflutate, 1 microgram
J0799 Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified   New
J0800 Injection, corticotropin, up to 40 units
J0801 Injection, corticotropin (acthar gel), up to 40 units
J0802 Injection, corticotropin (ani), up to 40 units
J0833 Injection, cosyntropin, not otherwise specified, 0.25 mg
J0834 Injection, cosyntropin, 0.25 mg
J0840 Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
J0841 Injection, crotalidae immune f(ab’)2 (equine), 120 mg
J0850 Injection, cytomegalovirus immune globulin intravenous (human), per vial
J0873 Injection, daptomycin (xellia) not therapeutically equivalent to j0878, 1 mg   New
J0874 Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
J0875 Injection, dalbavancin, 5 mg
J0877 Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg
J0878 Injection, daptomycin, 1 mg
J0879 Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J0882 Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
J0883 Injection, argatroban, 1 mg (for non-esrd use)
J0884 Injection, argatroban, 1 mg (for esrd on dialysis)
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J0886 Injection, epoetin alfa, 1000 units (for esrd on dialysis)
J0887 Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
J0888 Injection, epoetin beta, 1 microgram, (for non esrd use)
J0889 Daprodustat, oral, 1 mg, (for esrd on dialysis)
J0890 Injection, peginesatide, 0.1 mg (for esrd on dialysis)
J0891 Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
J0892 Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
J0893 Injection, decitabine (sun pharma) not therapeutically equivalent to j0894, 1 mg
J0894 Injection, decitabine, 1 mg
J0895 Injection, deferoxamine mesylate, 500 mg
J0896 Injection, luspatercept-aamt, 0.25 mg
J0897 Injection, denosumab, 1 mg
J0898 Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
J0899 Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
J0900 Injection, testosterone enanthate and estradiol valerate, up to 1 cc
J0945 Injection, brompheniramine maleate, per 10 mg
J1000 Injection, depo-estradiol cypionate, up to 5 mg
J1020 Injection, methylprednisolone acetate, 20 mg
J1030 Injection, methylprednisolone acetate, 40 mg
J1040 Injection, methylprednisolone acetate, 80 mg
J1050 Injection, medroxyprogesterone acetate, 1 mg
J1060 Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
J1070 Injection, testosterone cypionate, up to 100 mg
J1071 Injection, testosterone cypionate, 1 mg
J1080 Injection, testosterone cypionate, 1 cc, 200 mg
J1094 Injection, dexamethasone acetate, 1 mg
J1095 Injection, dexamethasone 9 percent, intraocular, 1 microgram
J1096Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
J1097Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1105Dexmedetomidine, oral, 1 mcg   New
J1110 Injection, dihydroergotamine mesylate, per 1 mg
J1120 Injection, acetazolamide sodium, up to 500 mg
J1130 Injection, diclofenac sodium, 0.5 mg
J1160 Injection, digoxin, up to 0.5 mg
J1162 Injection, digoxin immune fab (ovine), per vial
J1165 Injection, phenytoin sodium, per 50 mg
J1170 Injection, hydromorphone, up to 4 mg
J1180 Injection, dyphylline, up to 500 mg
J1190 Injection, dexrazoxane hydrochloride, per 250 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
J1201 Injection, cetirizine hydrochloride, 0.5 mg
J1205 Injection, chlorothiazide sodium, per 500 mg
J1212 Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
J1230 Injection, methadone hcl, up to 10 mg
J1240 Injection, dimenhydrinate, up to 50 mg
J1245 Injection, dipyridamole, per 10 mg
J1250 Injection, dobutamine hydrochloride, per 250 mg
J1260 Injection, dolasetron mesylate, 10 mg
J1265 Injection, dopamine hcl, 40 mg
J1267 Injection, doripenem, 10 mg
J1270 Injection, doxercalciferol, 1 mcg
J1290 Injection, ecallantide, 1 mg
J1300 Injection, eculizumab, 10 mg
J1301 Injection, edaravone, 1 mg
J1302 Injection, sutimlimab-jome, 10 mg
J1303 Injection, ravulizumab-cwvz, 10 mg
J1304 Injection, tofersen, 1 mg   New
J1305 Injection, evinacumab-dgnb, 5mg
J1306 Injection, inclisiran, 1 mg
J1320 Injection, amitriptyline hcl, up to 20 mg
J1322 Injection, elosulfase alfa, 1 mg
J1324 Injection, enfuvirtide, 1 mg
J1325 Injection, epoprostenol, 0.5 mg
J1327 Injection, eptifibatide, 5 mg
J1330 Injection, ergonovine maleate, up to 0.2 mg
J1335 Injection, ertapenem sodium, 500 mg
J1364 Injection, erythromycin lactobionate, per 500 mg
J1380 Injection, estradiol valerate, up to 10 mg
J1410 Injection, estrogen conjugated, per 25 mg
J1411 Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
J1412 Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes   New
J1413 Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose   New
J1426 Injection, casimersen, 10 mg
J1427 Injection, viltolarsen, 10 mg
J1428 Injection, eteplirsen, 10 mg
J1429 Injection, golodirsen, 10 mg
J1430 Injection, ethanolamine oleate, 100 mg
J1435 Injection, estrone, per 1 mg
J1436 Injection, etidronate disodium, per 300 mg
J1437 Injection, ferric derisomaltose, 10 mg
J1438 Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1439 Injection, ferric carboxymaltose, 1 mg
J1440 Fecal microbiota, live – jslm, 1 ml
J1442 Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
J1443 Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron
J1444 Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron
J1445 Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron
J1446 Injection, tbo-filgrastim, 5 micrograms
J1447 Injection, tbo-filgrastim, 1 microgram
J1448 Injection, trilaciclib, 1mg
J1449 Injection, eflapegrastim-xnst, 0.1 mg
J1450Injection fluconazole, 200 mg
J1451 Injection, fomepizole, 15 mg
J1452 Injection, fomivirsen sodium, intraocular, 1.65 mg
J1453 Injection, fosaprepitant, 1 mg
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
J1455 Injection, foscarnet sodium, per 1000 mg
J1456 Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
J1457 Injection, gallium nitrate, 1 mg
J1458 Injection, galsulfase, 1 mg
J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1460 Injection, gamma globulin, intramuscular, 1 cc
J1551 Injection, immune globulin (cutaquig), 100 mg
J1554 Injection, immune globulin (asceniv), 500 mg
J1555 Injection, immune globulin (cuvitru), 100 mg
J1556 Injection, immune globulin (bivigam), 500 mg
J1557 Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1558 Injection, immune globulin (xembify), 100 mg
J1559 Injection, immune globulin (hizentra), 100 mg
J1560 Injection, gamma globulin, intramuscular, over 10 cc
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
J1562 Injection, immune globulin (vivaglobin), 100 mg
J1566 Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
J1570 Injection, ganciclovir sodium, 500 mg
J1571 Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
J1572 Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1573 Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
J1574 Injection, ganciclovir sodium (exela) not therapeutically equivalent to j1570, 500 mg
J1575 Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
J1576 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1580 Injection, garamycin, gentamicin, up to 80 mg
J1590 Injection, gatifloxacin, 10 mg
J1595 Injection, glatiramer acetate, 20 mg
J1596 Injection, glycopyrrolate, 0.1 mg   New
J1599 Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
J1600 Injection, gold sodium thiomalate, up to 50 mg
J1602 Injection, golimumab, 1 mg, for intravenous use
J1610 Injection, glucagon hydrochloride, per 1 mg
J1611 Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
J1620 Injection, gonadorelin hydrochloride, per 100 mcg
J1626 Injection, granisetron hydrochloride, 100 mcg
J1627 Injection, granisetron, extended-release, 0.1 mg
J1628 Injection, guselkumab, 1 mg
J1630 Injection, haloperidol, up to 5 mg
J1631 Injection, haloperidol decanoate, per 50 mg
J1632 Injection, brexanolone, 1 mg
J1640 Injection, hemin, 1 mg
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units
J1643 Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units
J1644 Injection, heparin sodium, per 1000 units
J1645 Injection, dalteparin sodium, per 2500 iu
J1650 Injection, enoxaparin sodium, 10 mg
J1652 Injection, fondaparinux sodium, 0.5 mg
J1655 Injection, tinzaparin sodium, 1000 iu
J1670 Injection, tetanus immune globulin, human, up to 250 units
J1675 Injection, histrelin acetate, 10 micrograms
J1700 Injection, hydrocortisone acetate, up to 25 mg
J1710 Injection, hydrocortisone sodium phosphate, up to 50 mg
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg
J1725 Injection, hydroxyprogesterone caproate, 1 mg
J1726 Injection, hydroxyprogesterone caproate, (makena), 10 mg
J1729 Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
J1730 Injection, diazoxide, up to 300 mg
J1738 Injection, meloxicam, 1 mg
J1740 Injection, ibandronate sodium, 1 mg
J1741 Injection, ibuprofen, 100 mg
J1742 Injection, ibutilide fumarate, 1 mg
J1743 Injection, idursulfase, 1 mg
J1744 Injection, icatibant, 1 mg
J1745 Injection, infliximab, excludes biosimilar, 10 mg
J1746 Injection, ibalizumab-uiyk, 10 mg
J1747 Injection, spesolimab-sbzo, 1 mg
J1750 Injection, iron dextran, 50 mg
J1756 Injection, iron sucrose, 1 mg
J1786 Injection, imiglucerase, 10 units
J1790 Injection, droperidol, up to 5 mg
J1800 Injection, propranolol hcl, up to 1 mg
J1805 Injection, esmolol hydrochloride, 10 mg
J1806 Injection, esmolol hydrochloride (wg critical care) not therapeutically equivalent to j1805, 10 mg
J1810 Injection, droperidol and fentanyl citrate, up to 2 ml ampule
J1811 Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
J1812 Insulin (fiasp), per 5 units
J1813 Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
J1814 Insulin (lyumjev), per 5 units
J1815 Injection, insulin, per 5 units
J1817Insulin for administration through dme (i.e., insulin pump) per 50 units
J1823 Injection, inebilizumab-cdon, 1 mg
J1826 Injection, interferon beta-1a, 30 mcg
J1830 Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1833 Injection, isavuconazonium, 1 mg
J1835 Injection, itraconazole, 50 mg
J1836 Injection, metronidazole, 10 mg
J1840 Injection, kanamycin sulfate, up to 500 mg
J1850 Injection, kanamycin sulfate, up to 75 mg
J1885 Injection, ketorolac tromethamine, per 15 mg
J1890 Injection, cephalothin sodium, up to 1 gram
J1920 Injection, labetalol hydrochloride, 5 mg
J1921 Injection, labetalol hydrochloride (hikma) not therapeutically equivalent to j1920, 5 mg
J1930 Injection, lanreotide, 1 mg
J1931 Injection, laronidase, 0.1 mg
J1932 Injection, lanreotide, (cipla), 1 mg
J1939 Injection, bumetanide, 0.5 mg   New
J1940 Injection, furosemide, up to 20 mg
J1941 Injection, furosemide (furoscix), 20 mg
J1942 Injection, aripiprazole lauroxil, 1 mg
J1943 Injection, aripiprazole lauroxil, (aristada initio), 1 mg
J1944 Injection, aripiprazole lauroxil, (aristada), 1 mg
J1945 Injection, lepirudin, 50 mg
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg
J1951 Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
J1952 Leuprolide injectable, camcevi, 1 mg
J1953 Injection, levetiracetam, 10 mg
J1954 Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg
J1955 Injection, levocarnitine, per 1 gm
J1956 Injection, levofloxacin, 250 mg
J1960 Injection, levorphanol tartrate, up to 2 mg
J1961 Injection, lenacapavir, 1 mg
J1980 Injection, hyoscyamine sulfate, up to 0.25 mg
J1990 Injection, chlordiazepoxide hcl, up to 100 mg
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg
J2010 Injection, lincomycin hcl, up to 300 mg
J2020 Injection, linezolid, 200 mg
J2021 Injection, linezolid (hospira) not therapeutically equivalent to j2020, 200 mg
J2060 Injection, lorazepam, 2 mg
J2062 Loxapine for inhalation, 1 mg
J2150 Injection, mannitol, 25% in 50 ml
J2170 Injection, mecasermin, 1 mg
J2175 Injection, meperidine hydrochloride, per 100 mg
J2180 Injection, meperidine and promethazine hcl, up to 50 mg
J2182 Injection, mepolizumab, 1 mg
J2184 Injection, meropenem (b. braun) not therapeutically equivalent to j2185, 100 mg
J2185 Injection, meropenem, 100 mg
J2186 Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
J2210 Injection, methylergonovine maleate, up to 0.2 mg
J2212 Injection, methylnaltrexone, 0.1 mg
J2247 Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
J2248 Injection, micafungin sodium, 1 mg
J2249 Injection, remimazolam, 1 mg
J2250 Injection, midazolam hydrochloride, per 1 mg
J2251 Injection, midazolam hydrochloride (wg critical care) not therapeutically equivalent to j2250, per 1 mg
J2260 Injection, milrinone lactate, 5 mg
J2265 Injection, minocycline hydrochloride, 1 mg
J2270 Injection, morphine sulfate, up to 10 mg
J2271 Injection, morphine sulfate, 100mg
J2272 Injection, morphine sulfate (fresenius kabi) not therapeutically equivalent to j2270, up to 10 mg
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
J2275 Injection, morphine sulfate (preservative-free sterile solution), per 10 mg
J2278 Injection, ziconotide, 1 microgram
J2280 Injection, moxifloxacin, 100 mg
J2281 Injection, moxifloxacin (fresenius kabi) not therapeutically equivalent to j2280, 100 mg
J2300 Injection, nalbuphine hydrochloride, per 10 mg
J2305 Injection, nitroglycerin, 5 mg
J2310 Injection, naloxone hydrochloride, per 1 mg
J2311 Injection, naloxone hydrochloride (zimhi), 1 mg
J2315 Injection, naltrexone, depot form, 1 mg
J2320 Injection, nandrolone decanoate, up to 50 mg
J2323 Injection, natalizumab, 1 mg
J2325 Injection, nesiritide, 0.1 mg
J2326 Injection, nusinersen, 0.1 mg
J2327 Injection, risankizumab-rzaa, intravenous, 1 mg
J2329 Injection, ublituximab-xiiy, 1mg
J2350 Injection, ocrelizumab, 1 mg
J2353 Injection, octreotide, depot form for intramuscular Injection, 1 mg
J2354 Injection, octreotide, non-depot form for subcutaneous or intravenous  Injection, 25 mcg
J2355 Injection, oprelvekin, 5 mg
J2356 Injection, tezepelumab-ekko, 1 mg
J2357 Injection, omalizumab, 5 mg
J2358 Injection, olanzapine, long-acting, 1 mg
J2359 Injection, olanzapine, 0.5 mg
J2360 Injection, orphenadrine citrate, up to 60 mg
J2370 Injection, phenylephrine hcl, up to 1 ml
J2371 Injection, phenylephrine hydrochloride, 20 micrograms
J2372 Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
J2400 Injection, chloroprocaine hydrochloride, per 30 ml
J2401 Injection, chloroprocaine hydrochloride, per 1 mg
J2402 Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
J2403 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
J2404 Injection, nicardipine, 0.1 mg   New
J2405 Injection, ondansetron hydrochloride, per 1 mg
J2406 Injection, oritavancin (kimyrsa), 10 mg
J2407 Injection, oritavancin (orbactiv), 10 mg
J2410 Injection, oxymorphone hcl, up to 1 mg
J2425 Injection, palifermin, 50 micrograms
J2426 Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
J2427 Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
J2430 Injection, pamidronate disodium, per 30 mg
J2440 Injection, papaverine hcl, up to 60 mg
J2460 Injection, oxytetracycline hcl, up to 50 mg
J2469 Injection, palonosetron hcl, 25 mcg
J2501 Injection, paricalcitol, 1 mcg
J2502 Injection, pasireotide long acting, 1 mg
J2503 Injection, pegaptanib sodium, 0.3 mg
J2504 Injection, pegademase bovine, 25 iu
J2505 Injection, pegfilgrastim, 6 mg
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
J2507 Injection, pegloticase, 1 mg
J2508 Injection, pegunigalsidase alfa-iwxj, 1 mg   New
J2510 Injection, penicillin g procaine, aqueous, up to 600,000 units
J2513 Injection, pentastarch, 10% solution, 100 ml
J2515 Injection, pentobarbital sodium, per 50 mg
J2540 Injection, penicillin g potassium, up to 600,000 units
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
J2545 Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
J2547 Injection, peramivir, 1 mg
J2550 Injection, promethazine hcl, up to 50 mg
J2560 Injection, phenobarbital sodium, up to 120 mg
J2561 Injection, phenobarbital sodium (sezaby), 1 mg
J2562 Injection, plerixafor, 1 mg
J2590 Injection, oxytocin, up to 10 units
J2597 Injection, desmopressin acetate, per 1 mcg
J2598 Injection, vasopressin, 1 unit
J2599 Injection, vasopressin (american regent) not therapeutically equivalent to j2598, 1 unit
J2650 Injection, prednisolone acetate, up to 1 ml
J2670 Injection, tolazoline hcl, up to 25 mg
J2675 Injection, progesterone, per 50 mg
J2679 Injection, fluphenazine hcl, 1.25 mg   New
J2680 Injection, fluphenazine decanoate, up to 25 mg
J2690 Injection, procainamide hcl, up to 1 gm
J2700 Injection, oxacillin sodium, up to 250 mg
J2704 Injection, propofol, 10 mg
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg
J2720 Injection, protamine sulfate, per 10 mg
J2724 Injection, protein c concentrate, intravenous, human, 10 iu
J2725 Injection, protirelin, per 250 mcg
J2730 Injection, pralidoxime chloride, up to 1 gm
J2760 Injection, phentolamine mesylate, up to 5 mg
J2765 Injection, metoclopramide hcl, up to 10 mg
J2770 Injection, quinupristin/dalfopristin, 500 mg (150/350)
J2777 Injection, faricimab-svoa, 0.1 mg
J2778 Injection, ranibizumab, 0.1 mg
J2779 Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
J2780 Injection, ranitidine hydrochloride, 25 mg
J2781 Injection, pegcetacoplan, intravitreal, 1 mg
J2783 Injection, rasburicase, 0.5 mg
J2785 Injection, regadenoson, 0.1 mg
J2786 Injection, reslizumab, 1 mg
J2787 Riboflavin 5′-phosphate, ophthalmic solution, up to 3 ml
J2788 Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
J2791 Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu
J2792 Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
J2793 Injection, rilonacept, 1 mg
J2794 Injection, risperidone (risperdal consta), 0.5 mg
J2795 Injection, ropivacaine hydrochloride, 1 mg
J2796 Injection, romiplostim, 10 micrograms
J2797 Injection, rolapitant, 0.5 mg
J2798 Injection, risperidone, (perseris), 0.5 mg
J2799 Injection, risperidone (uzedy), 1 mg   New
J2800 Injection, methocarbamol, up to 10 ml
J2805 Injection, sincalide, 5 micrograms
J2806 Injection, sincalide (maia) not therapeutically equivalent to j2805, 5 micrograms
J2810 Injection, theophylline, per 40 mg
J2820 Injection, sargramostim (gm-csf), 50 mcg
J2840 Injection, sebelipase alfa, 1 mg
J2850 Injection, secretin, synthetic, human, 1 microgram
J2860 Injection, siltuximab, 10 mg
J2910 Injection, aurothioglucose, up to 50 mg
J2916 Injection, sodium ferric gluconate complex in sucrose Injection, 12.5 mg
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg
J2940 Injection, somatrem, 1 mg
J2941 Injection, somatropin, 1 mg
J2950 Injection, promazine hcl, up to 25 mg
J2993 Injection, reteplase, 18.1 mg
J2995 Injection, streptokinase, per 250,000 iu
J2997 Injection, alteplase recombinant, 1 mg
J2998 Injection, plasminogen, human-tvmh, 1 mg
J3000 Injection, streptomycin, up to 1 gm
J3010 Injection, fentanyl citrate, 0.1 mg
J3030 Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
J3031 Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
J3032 Injection, eptinezumab-jjmr, 1 mg
J3060 Injection, taliglucerase alfa, 10 units
J3070 Injection, pentazocine, 30 mg
J3090 Injection, tedizolid phosphate, 1 mg
J3095 Injection, telavancin, 10 mg
J3101 Injection, tenecteplase, 1 mg
J3105 Injection, terbutaline sulfate, up to 1 mg
J3110 Injection, teriparatide, 10 mcg
J3111 Injection, romosozumab-aqqg, 1 mg
J3120 Injection, testosterone enanthate, up to 100 mg
J3121 Injection, testosterone enanthate, 1 mg
J3130 Injection, testosterone enanthate, up to 200 mg
J3140 Injection, testosterone suspension, up to 50 mg
J3145 Injection, testosterone undecanoate, 1 mg
J3150 Injection, testosterone propionate, up to 100 mg
J3230 Injection, chlorpromazine hcl, up to 50 mg
J3240 Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
J3241 Injection, teprotumumab-trbw, 10 mg
J3243 Injection, tigecycline, 1 mg
J3244 Injection, tigecycline (accord) not therapeutically equivalent to j3243, 1 mg
J3245 Injection, tildrakizumab, 1 mg
J3246 Injection, tirofiban hcl, 0.25 mg
J3250 Injection, trimethobenzamide hcl, up to 200 mg
J3260 Injection, tobramycin sulfate, up to 80 mg
J3262 Injection, tocilizumab, 1 mg
J3265 Injection, torsemide, 10 mg/ml
J3280 Injection, thiethylperazine maleate, up to 10 mg
J3285 Injection, treprostinil, 1 mg
J3299 Injection, triamcinolone acetonide (xipere), 1 mg
J3300 Injection, triamcinolone acetonide, preservative free, 1 mg
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
J3302 Injection, triamcinolone diacetate, per 5 mg
J3303 Injection, triamcinolone hexacetonide, per 5 mg
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
J3305 Injection, trimetrexate glucuronate, per 25 mg
J3310 Injection, perphenazine, up to 5 mg
J3315 Injection, triptorelin pamoate, 3.75 mg
J3316 Injection, triptorelin, extended-release, 3.75 mg
J3320 Injection, spectinomycin dihydrochloride, up to 2 gm
J3350Injection, urea, up to 40 gm
J3355Injection, urofollitropin, 75 iu
J3357Ustekinumab, for subcutaneous Injection, 1 mg
J3358Ustekinumab, for intravenous Injection, 1 mg
J3360 Injection, diazepam, up to 5 mg
J3364 Injection, urokinase, 5000 iu vial
J3365 Injection, iv, urokinase, 250,000 i.u. vial
J3370 Injection, vancomycin hcl, 500 mg
J3371 Injection, vancomycin hcl (mylan) not therapeutically equivalent to j3370, 500 mg
J3372 Injection, vancomycin hcl (xellia) not therapeutically equivalent to j3370, 500 mg
J3380 Injection, vedolizumab, 1 mg
J3385 Injection, velaglucerase alfa, 100 units
J3396 Injection, verteporfin, 0.1 mg
J3397 Injection, vestronidase alfa-vjbk, 1 mg
J3398 Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
J3399 Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5×10^15 vector genomes
J3400 Injection, triflupromazine hcl, up to 20 mg
J3401 Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml   New
J3410 Injection, hydroxyzine hcl, up to 25 mg
J3411 Injection, thiamine hcl, 100 mg
J3415 Injection, pyridoxine hcl, 100 mg
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
J3425 Injection, hydroxocobalamin, 10 mcg   New
J3430 Injection, phytonadione (vitamin k), per 1 mg
J3465 Injection, voriconazole, 10 mg
J3470 Injection, hyaluronidase, up to 150 units
J3471 Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)
J3472 Injection, hyaluronidase, ovine, preservative free, per 1000 usp units
J3473 Injection, hyaluronidase, recombinant, 1 usp unit
J3475 Injection, magnesium sulfate, per 500 mg
J3480 Injection, potassium chloride, per 2 meq
J3485 Injection, zidovudine, 10 mg
J3486 Injection, ziprasidone mesylate, 10 mg
J3489 Injection, zoledronic acid, 1 mg
J3490 Unclassified drugs
J3520 Edetate disodium, per 150 mg
J3530 Nasal vaccine inhalation
J3535 Drug administered through a metered dose inhaler
J3570 Laetrile, amygdalin, vitamin b17
J3590 Unclassified biologics
J3591 Unclassified drug or biological used for esrd on dialysis
J7030 Infusion, normal saline solution , 1000 cc
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
J7042 5% dextrose/normal saline (500 ml = 1 unit)
J7050 Infusion, normal saline solution, 250 cc
J7060 5% dextrose/water (500 ml = 1 unit)
J7070 Infusion, d5w, 1000 cc
J7100 Infusion, dextran 40, 500 ml
J7110 Infusion, dextran 75, 500 ml
J7120 Ringers lactate infusion, up to 1000 cc
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc
J7131 Hypertonic saline solution, 1 ml
J7168 Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
J7169 Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
J7170 Injection, emicizumab-kxwh, 0.5 mg
J7175 Injection, factor x, (human), 1 i.u.
J7177 Injection, human fibrinogen concentrate (fibryga), 1 mg
J7178 Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
J7179 Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
J7180 Injection, factor xiii (antihemophilic factor, human), 1 i.u.
J7181 Injection, factor xiii a-subunit, (recombinant), per iu
J7182 Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu
J7183 Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco
J7185 Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.
J7186 Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
J7187 Injection, von willebrand factor complex (humate-p), per iu vwf:rco
J7188 Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
J7189 Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
J7190 Factor viii (antihemophilic factor, human) per i.u.
J7191 Factor viii (antihemophilic factor (porcine)), per i.u.
J7192 Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified
J7193 Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.
J7194 Factor ix, complex, per i.u.
J7195 Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified
J7196 Injection, antithrombin recombinant, 50 i.u.
J7197 Antithrombin iii (human), per i.u.
J7198 Anti-inhibitor, per i.u.
J7199 Hemophilia clotting factor, not otherwise classified
J7200 Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu
J7201 Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.
J7202 Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.
J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
J7204 Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
J7205 Injection, factor viii fc fusion protein (recombinant), per iu
J7207 Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
J7208 Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
J7209 Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.
J7210 Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
J7211 Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.
J7212 Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
J7213 Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
J7214 Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.
J7294 Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each
J7295 Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
J7296 Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
J7297 Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
J7300 Intrauterine copper contraceptive
J7301 Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
J7302 Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
J7303 Contraceptive supply, hormone containing vaginal ring, each
J7304 Contraceptive supply, hormone containing patch, each
J7306 Levonorgestrel (contraceptive) implant system, including implants and supplies
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
J7309 Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
J7310Ganciclovir, 4.5 mg, long-acting implant
J7311 Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg
J7313 Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
J7314 Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
J7315 Mitomycin, ophthalmic, 0.2 mg
J7316 Injection, ocriplasmin, 0.125 mg
J7318 Hyaluronan or derivative, durolane, for intra-articular  Injection, 1 mg
J7320 Hyaluronan or derivitive, genvisc 850, for intra-articular  Injection, 1 mg
J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular Injection, per dose
J7322 Hyaluronan or derivative, hymovis, for intra-articular Injection, 1 mg
J7323 Hyaluronan or derivative, euflexxa, for intra-articular  Injection, per dose
J7324 Hyaluronan or derivative, orthovisc, for intra-articular  Injection, per dose
J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular  Injection, 1 mg
J7326 Hyaluronan or derivative, gel-one, for intra-articular Injection, per dose
J7327 Hyaluronan or derivative, monovisc, for intra-articular Injection, per dose
J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular Injection, 0.1 mg
J7329 Hyaluronan or derivative, trivisc, for intra-articular Injection, 1 mg
J7330 Autologous cultured chondrocytes, implant
J7331 Hyaluronan or derivative, synojoynt, for intra-articular Injection, 1 mg
J7332 Hyaluronan or derivative, triluron, for intra-articular Injection, 1 mg
J7333 Hyaluronan or derivative, visco-3, for intra-articular Injection, per dose
J7335 Capsaicin 8% patch, per 10 square centimeters
J7336 Capsaicin 8% patch, per square centimeter
J7340 Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml
J7342 Instillation, ciprofloxacin otic suspension, 6 mg
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
J7351 Injection, bimatoprost, intracameral implant, 1 microgram
J7352 Afamelanotide implant, 1 mg
J7353 Anacaulase-bcdb, 8.8% gel, 1 gram
J7401 Mometasone furoate sinus implant, 10 micrograms
J7402 Mometasone furoate sinus implant, (sinuva), 10 micrograms
J7500 Azathioprine, oral, 50 mg
J7501 Azathioprine, parenteral, 100 mg
J7502 Cyclosporine, oral, 100 mg
J7503 Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
J7504 Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
J7505 Muromonab-cd3, parenteral, 5 mg
J7506 Prednisone, oral, per 5 mg
J7507 Tacrolimus, immediate release, oral, 1 mg
J7508 Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
J7509 Methylprednisolone oral, per 4 mg
J7510 Prednisolone oral, per 5 mg
J7511 Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
J7512 Prednisone, immediate release or delayed release, oral, 1 mg
J7513 Daclizumab, parenteral, 25 mg
J7515 Cyclosporine, oral, 25 mg
J7516 Cyclosporin, parenteral, 250 mg
J7517 Mycophenolate mofetil, oral, 250 mg
J7518 Mycophenolic acid, oral, 180 mg
J7519 Injection, mycophenolate mofetil, 10 mg
J7520 Sirolimus, oral, 1 mg
J7525 Tacrolimus, parenteral, 5 mg
J7527 Everolimus, oral, 0.25 mg
J7599 Immunosuppressive drug, not otherwise classified
J7604 Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
J7605 Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
J7606 Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
J7607 Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
J7608 Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
J7609 Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
J7610 Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
J7612 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
J7614 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
J7615 Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
J7622 Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7624 Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7626 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
J7627 Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
J7628 Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7629 Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7631 Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
J7632 Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
J7633 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
J7634 Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
J7635 Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7636 Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7637 Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7638 Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7639 Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
J7640 Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
J7641 Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
J7642 Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7643 Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
J7645 Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7647 Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7648 Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
J7649 Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
J7650 Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7657 Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7658 Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
J7659 Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
J7660 Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7665 Mannitol, administered through an inhaler, 5 mg
J7667 Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
J7668 Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
J7669 Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
J7670 Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
J7674 Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
J7676 Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
J7677 Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
J7680 Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7681 Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7682 Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
J7683 Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7684 Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7685 Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
J7686 Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
J7699 Noc drugs, inhalation solution administered through dme
J7799 Noc drugs, other than inhalation drugs, administered through dme
J7999 Compounded drug, not otherwise classified
J8498 Antiemetic drug, rectal/suppository, not otherwise specified
J8499 Prescription drug, oral, non chemotherapeutic, nos
J8501 Aprepitant, oral, 5 mg
J8510 Busulfan; oral, 2 mg
J8515Cabergoline, oral, 0.25 mg
J8520 Capecitabine, oral, 150 mg
J8521 Capecitabine, oral, 500 mg
J8530 Cyclophosphamide; oral, 25 mg
J8540 Dexamethasone, oral, 0.25 mg
J8560 Etoposide; oral, 50 mg
J8562 Fludarabine phosphate, oral, 10 mg
J8565 Gefitinib, oral, 250 mg
J8597 Antiemetic drug, oral, not otherwise specified
J8600 Melphalan; oral, 2 mg
J8610 Methotrexate; oral, 2.5 mg
J8650 Nabilone, oral, 1 mg
J8655 Netupitant 300 mg and palonosetron 0.5 mg, oral
J8670 Rolapitant, oral, 1 mg
J8700 Temozolomide, oral, 5 mg
J8705 Topotecan, oral, 0.25 mg
J8999 Prescription drug, oral, chemotherapeutic, nos
J9000 Injection, doxorubicin hydrochloride, 10 mg
J9010 Injection, alemtuzumab, 10 mg
J9015 Injection, aldesleukin, per single use vial
J9017 Injection, arsenic trioxide, 1 mg
J9019 Injection, asparaginase (erwinaze), 1,000 iu
J9020 Injection, asparaginase, not otherwise specified, 10,000 units
J9021 Injection, asparaginase, recombinant, (rylaze), 0.1 mg
J9022 Injection, atezolizumab, 10 mg
J9023 Injection, avelumab, 10 mg
J9025 Injection, azacitidine, 1 mg
J9027 Injection, clofarabine, 1 mg
J9029 Injection, nadofaragene firadenovec-vncg, per therapeutic dose
J9030 Bcg live intravesical instillation, 1 mg
J9031 Bcg (intravesical) per instillation
J9032 Injection, belinostat, 10 mg
J9033 Injection, bendamustine hcl (treanda), 1 mg
J9034 Injection, bendamustine hcl (bendeka), 1 mg
J9035 Injection, bevacizumab, 10 mg
J9036 Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
J9037 Injection, belantamab mafodotin-blmf, 0.5 mg
J9039 Injection, blinatumomab, 1 microgram
J9040 Injection, bleomycin sulfate, 15 units
J9041 Injection, bortezomib, 0.1 mg
J9042 Injection, brentuximab vedotin, 1 mg
J9043 Injection, cabazitaxel, 1 mg
J9044 Injection, bortezomib, not otherwise specified, 0.1 mg
J9045 Injection, carboplatin, 50 mg
J9046 Injection, bortezomib, (dr. reddy’s), not therapeutically equivalent to j9041, 0.1 mg
J9047 Injection, carfilzomib, 1 mg
J9048 Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
J9049 Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
J9050 Injection, carmustine, 100 mg
J9051 Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
J9052 Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg   New
J9055 Injection, cetuximab, 10 mg
J9056 Injection, bendamustine hydrochloride (vivimusta), 1 mg
J9057 Injection, copanlisib, 1 mg
J9058 Injection, bendamustine hydrochloride (apotex), 1 mg
J9059 Injection, bendamustine hydrochloride (baxter), 1 mg
J9060 Injection, cisplatin, powder or solution, 10 mg
J9061 Injection, amivantamab-vmjw, 2 mg
J9063 Injection, mirvetuximab soravtansine-gynx, 1 mg
J9064 Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
J9065 Injection, cladribine, per 1 mg
J9070 Cyclophosphamide, 100 mg
J9071 Injection, cyclophosphamide, (auromedics), 5 mg
J9072 Injection, cyclophosphamide, (dr. reddy’s), 5 mg   New
J9098 Injection, cytarabine liposome, 10 mg
J9100 Injection, cytarabine, 100 mg
J9118 Injection, calaspargase pegol-mknl, 10 units
J9119 Injection, cemiplimab-rwlc, 1 mg
J9120 Injection, dactinomycin, 0.5 mg
J9130 Dacarbazine, 100 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J9145 Injection, daratumumab, 10 mg
J9150 Injection, daunorubicin, 10 mg
J9151 Injection, daunorubicin citrate, liposomal formulation, 10 mg
J9153 Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
J9155 Injection, degarelix, 1 mg
J9160 Injection, denileukin diftitox, 300 micrograms   Discontinued
J9165 Injection, diethylstilbestrol diphosphate, 250 mg
J9171 Injection, docetaxel, 1 mg
J9172 Injection, docetaxel (ingenus) not therapeutically equivalent to j9171, 1 mg   New
J9173 Injection, durvalumab, 10 mg
J9175 Injection, elliotts’ b solution, 1 ml
J9176 Injection, elotuzumab, 1 mg
J9177 Injection, enfortumab vedotin-ejfv, 0.25 mg
J9178 Injection, epirubicin hcl, 2 mg
J9179 Injection, eribulin mesylate, 0.1 mg
J9181 Injection, etoposide, 10 mg
J9185 Injection, fludarabine phosphate, 50 mg
J9190 Injection, fluorouracil, 500 mg
J9196 Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
J9198 Injection, gemcitabine hydrochloride, (infugem), 100 mg
J9199 Injection, gemcitabine hydrochloride (infugem), 200 mg
J9200 Injection, floxuridine, 500 mg
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
J9202 Goserelin acetate implant, per 3.6 mg
J9203 Injection, gemtuzumab ozogamicin, 0.1 mg
J9204 Injection, mogamulizumab-kpkc, 1 mg
J9205 Injection, irinotecan liposome, 1 mg
J9206 Injection, irinotecan, 20 mg
J9207 Injection, ixabepilone, 1 mg
J9208 Injection, ifosfamide, 1 gram
J9209 Injection, mesna, 200 mg
J9210 Injection, emapalumab-lzsg, 1 mg
J9211 Injection, idarubicin hydrochloride, 5 mg
J9212 Injection, interferon alfacon-1, recombinant, 1 microgram
J9213 Injection, interferon, alfa-2a, recombinant, 3 million units
J9214 Injection, interferon, alfa-2b, recombinant, 1 million units
J9215 Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
J9216 Injection, interferon, gamma 1-b, 3 million units
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J9218 Leuprolide acetate, per 1 mg
J9219 Leuprolide acetate implant, 65 mg
J9223 Injection, lurbinectedin, 0.1 mg
J9225 Histrelin implant (vantas), 50 mg
J9226 Histrelin implant (supprelin la), 50 mg
J9227 Injection, isatuximab-irfc, 10 mg
J9228 Injection, ipilimumab, 1 mg
J9229 Injection, inotuzumab ozogamicin, 0.1 mg
J9230 Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
J9245 Injection, melphalan hydrochloride, not otherwise specified, 50 mg
J9246 Injection, melphalan (evomela), 1 mg
J9247 Injection, melphalan flufenamide, 1mg
J9250 Methotrexate sodium, 5 mg
J9255 Injection, methotrexate (accord) not therapeutically equivalent to j9250 and j9260, 50 mg   New
J9258 Injection, paclitaxel protein-bound particles (teva) not therapeutically equivalent to j9264, 1 mg   New
J9259 Injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg
J9260 Methotrexate sodium, 50 mg
J9261 Injection, nelarabine, 50 mgJ9262 Injection, omacetaxine mepesuccinate, 0.01 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9264 Injection, paclitaxel protein-bound particles, 1 mg
J9265 Injection, paclitaxel, 30 mg
J9266 Injection, pegaspargase, per single dose vial
J9267 Injection, paclitaxel, 1 mg
J9268 Injection, pentostatin, 10 mg
J9269 Injection, tagraxofusp-erzs, 10 micrograms
J9270 Injection, plicamycin, 2.5 mg
J9271 Injection, pembrolizumab, 1 mg
J9272 Injection, dostarlimab-gxly, 10 mg
J9273 Injection, tisotumab vedotin-tftv, 1 mg
J9274 Injection, tebentafusp-tebn, 1 microgram
J9280 Injection, mitomycin, 5 mg
J9281Mitomycin pyelocalyceal instillation, 1 mg
J9285 Injection, olaratumab, 10 mg
J9286 Injection, glofitamab-gxbm, 2.5 mg   New
J9293 Injection, mitoxantrone hydrochloride, per 5 mg
J9294 Injection, pemetrexed (hospira) not therapeutically equivalent to j9305, 10 mg
J9295 Injection, necitumumab, 1 mg
J9296 Injection, pemetrexed (accord) not therapeutically equivalent to j9305, 10 mg
J9297 Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
J9298 Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
J9299 Injection, nivolumab, 1 mg
J9300 Injection, gemtuzumab ozogamicin, 5 mg
J9301 Injection, obinutuzumab, 10 mg
J9302 Injection, ofatumumab, 10 mg
J9303 Injection, panitumumab, 10 mg
J9304 Injection, pemetrexed (pemfexy), 10 mg
J9305 Injection, pemetrexed, not otherwise specified, 10 mg
J9306 Injection, pertuzumab, 1 mg
J9307 Injection, pralatrexate, 1 mg
J9308 Injection, ramucirumab, 5 mg
J9309 Injection, polatuzumab vedotin-piiq, 1 mg
J9310 Injection, rituximab, 100 mg
J9311 Injection, rituximab 10 mg and hyaluronidase
J9312 Injection, rituximab, 10 mg
J9313 Injection, moxetumomab pasudotox-tdfk, 0.01 mg
J9314 Injection, pemetrexed (teva) not therapeutically equivalent to j9305, 10 mg
J9315 Injection, romidepsin, 1 mg
J9316 Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
J9317 Injection, sacituzumab govitecan-hziy, 2.5 mg
J9318 Injection, romidepsin, non-lyophilized, 0.1 mg
J9319 Injection, romidepsin, lyophilized, 0.1 mg
J9320 Injection, streptozocin, 1 gram
J9321 Injection, epcoritamab-bysp, 0.16 mg   New
J9322 Injection, pemetrexed (bluepoint) not therapeutically equivalent to j9305, 10 mg
J9323 Injection, pemetrexed ditromethamine, 10 mg
J9324 Injection, pemetrexed (pemrydi rtu), 10 mg   New
J9325 Injection, talimogene laherparepvec, per 1 million plaque forming units
J9328 Injection, temozolomide, 1 mg
J9330 Injection, temsirolimus, 1 mg
J9331 Injection, sirolimus protein-bound particles, 1 mg
J9332 Injection, efgartigimod alfa-fcab, 2mg
J9333 Injection, rozanolixizumab-noli, 1 mg   New
J9334 Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc   New
J9340 Injection, thiotepa, 15 mg
J9345 Injection, retifanlimab-dlwr, 1 mg
J9347 Injection, tremelimumab-actl, 1 mg
J9348 Injection, naxitamab-gqgk, 1 mg
J9349 Injection, tafasitamab-cxix, 2 mg
J9350 Injection, mosunetuzumab-axgb, 1 mg
J9351 Injection, topotecan, 0.1 mg
J9352 Injection, trabectedin, 0.1 mg
J9353 Injection, margetuximab-cmkb, 5 mg
J9354 Injection, ado-trastuzumab emtansine, 1 mg
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg
J9356 Injection, trastuzumab, 10 mg and hyaluronidase-oysk
J9357 Injection, valrubicin, intravesical, 200 mg
J9358 Injection, fam-trastuzumab deruxtecan-nxki, 1 mg
J9359 Injection, loncastuximab tesirine-lpyl, 0.075 mg
J9360 Injection, vinblastine sulfate, 1 mg
J9370 Vincristine sulfate, 1 mg
J9371 Injection, vincristine sulfate liposome, 1 mg
J9380 Injection, teclistamab-cqyv, 0.5 mg
J9381 Injection, teplizumab-mzwv, 5 mcg
J9390 Injection, vinorelbine tartrate, 10 mg
J9393 Injection, fulvestrant (teva) not therapeutically equivalent to j9395, 25 mg
J9394 Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
J9395 Injection, fulvestrant, 25 mg
J9400 Injection, ziv-aflibercept, 1 mg
J9600 Injection, porfimer sodium, 75 mg
J9999 Not otherwise classified, antineoplastic drugs

What are HCPCS J Codes?

HCPCS J-Codes are part of a standardized coding system used to identify and bill for drugs, supplies, and services. These codes are employed for documenting injectable medications typically not suitable for self-administration. This includes chemotherapy, immunosuppressive drugs, inhalation solutions, and certain orally administered medications. Moreover these codes specifically target drugs administered through routes other than oral methods, ensuring accurate reimbursement and uniform coding practices.

Drugs Administered Beyond Oral Methods

J Codes primarily cover drugs administered through various non-oral routes, including injections, infusions, and other parenteral methods. This includes medications delivered intravenously, intramuscularly, subcutaneously, and through other non-oral routes.

Emphasis on Chemotherapy Drugs

One significant subset of J-Codes focuses on chemotherapy drugs. These codes are instrumental in accurately documenting and billing for the administration of chemotherapy agents, crucial in the treatment of various cancers.

How to Assign J Codes?

Healthcare professionals must carefully select J-Codes based on specific criteria, including the drug administered, dosage, and route of administration. Additionally accurate code assignment is crucial for proper documentation and billing.

Thorough documentation of the drug administration process is essential for proper code assignment. Healthcare providers should include information on the drug name, dosage, route of administration, and any relevant patient-specific details.

Conclusion

In conclusion, chemotherapy drugs Codes is paramount for healthcare professionals seeking to navigate the intricate landscape of medical billing and coding. Navigate our guide with confidence; furthermore, Check our complete HCPCS Codes Lookup to enhance your coding proficiency. Moreover, Empower yourself and your healthcare organization with the knowledge and precision required for efficient billing, compliance, and optimal patient care.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *